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Research
AbstrACt
study objective To evaluate the implementation of the 
Ohio Emergency and Acute Care Facility Opioids and Other 
Controlled Substances Prescribing Guidelines and their 
perceived impact on local policies and practice.
Methods The study design was a cross-sectional survey 
of emergency department (ED) medical directors, or 
appropriate person identified by the hospital, perception 
of the impact of the Ohio ED Opioid Prescribing Guidelines 
on their departments practice. All hospitals with an ED in 
Ohio were contacted throughout October and November 
2016. Distribution followed Dillman’s Tailored Design 
Method, augmented with telephone recruitment. Hospital 
chief executive officers were contacted when necessary 
to encourage ED participation. Descriptive statistics were 
used to assess the impact of opioid prescribing policies on 
prescribing practices.
results A 92% response rate was obtained (150/163 
EDs). In total, 112 (75%) of the respondents stated that 
their ED has an opioid prescribing policy, is adopting one or 
is implementing prescribing guidelines without a specific 
policy. Of these 112 EDs, 81 (72%) based their policy on 
the Ohio ED Opioid Prescribing Guidelines. The majority of 
respondents strongly agreed/agreed that the prescribing 
guidelines have increased the use of the prescription 
drug monitoring programme (86%) and have reduced 
inappropriate opioid prescribing (71%).
Conclusion This study showed that the Ohio ED Opioid 
Prescribing Guidelines have been widely disseminated and 
that the majority of EDs in Ohio are using them to develop 
local policies. The majority of respondents believed 
that the Ohio opioid prescribing guidelines reduced 
inappropriate opioid prescribing. However, prescribing 
practices still varied greatly between EDs.
IntroduCtIon 
background
Drug overdoses are the leading cause of unin-
tentional death in the USA, driven largely by 
opioids (66%), both prescription and illicit.1 2 
In total, 40% of opioid-related deaths are due 
to a prescription opioid, with the remainder 
primarily driven by heroin and illicitly manu-
factured fentanyl (IMF).3 Although heroin 
and IMF-related deaths are the primary cause 
of opioid-related deaths in the USA, there 
are significant geographical variations in 
opioid prescribing practices and involvement 
of specific opioid compounds in overdose 
deaths.2 4 Reducing unnecessary exposure to 
prescription opioids may prevent the devel-
opment of opioid use disorder that is later 
supplemented or replaced by illicit opioids.5 
This has led to the implementation of 
multiple strategies aimed at improving opioid 
prescribing around the USA.2 6 Such strate-
gies appear to be improving the situations in 
some states, as the rates of overdose deaths 
involving a prescription (age adjusted) have 
steadied from 2011 to 20155 and the annual 
opioid prescribing rate has decreased from 
2012 to 2015.4 
This paper will focus on strategies used in 
the emergency room setting in Ohio, as Ohio 
had the third highest rate of prescription 
opioid-related overdose deaths and highest 
number of prescription opioid-related 
overdose deaths in the USA in 2016.7 Ohio 
has persistently had high overdose deaths 
strengths and limitations of this study
 ► All emergency departments (EDs) in hospitals in 
Ohio were included in the study.
 ► A large response rate of 92% (150/163) was ob-
tained for the survey.
 ► Survey reported ED medical directors’ perceptions 
of prescribing practices in their EDs.
 ► Survey results are self-reported and may be influ-
enced by recall or social desirability bias.
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over the last decade and has been comprehensive in its 
approach to reduce them.5 8 Many state-based initiatives 
were developed by the Governor’s Cabinet Opiate Action 
Team (GCOAT) and have also included the development 
of numerous opioid prescribing guidelines. This includes 
the Ohio Emergency and Acute Care Facility Opioids and 
Other Controlled Substances Prescribing Guidelines, 
referred to as the Ohio emergency department (ED) 
Opioid Prescribing Guidelines, in 2012.9 Similar guide-
lines have been released by the American College of 
Emergency Physicians (ACEP) in 2012.10 The Ohio guide-
lines were endorsed and publicised by nine organisations, 
including the Ohio chapter of the ACEP, the Ohio State 
Medical Association and the Ohio Hospital Association.9
Physicians working in ED may require assistance as it has 
been estimated that up to 42% of EDs may be misused by 
patients.11 Development and dissemination of high-quality 
clinical practice guidelines can assist physicians in making 
informed prescribing decisions while mitigating the risks 
associated with medications, such as opioids. A qualitative 
study of 61 emergency physicians presented at the 2012 
national ACEP research and education conference found 
that, in general, physicians viewed opioid prescribing guide-
lines in EDs favourably.12 They believed the guidelines 
assisted in standardising practice patterns at the institu-
tional level, reduced the frequency and dosage of opioid 
prescriptions, improved patient safety and protected them 
from liability and patient complaints. However, it was also 
noted that many physicians were unaware of specific recom-
mendations listed in the guidelines.12 Recent evidence 
further supports this as opioid prescribing has declined in 
Ohio by ED physicians since the release of the Ohio ED 
Opioid Prescribing Guidelines.13 However, it is unknown 
which recommendations in the guidelines have led to this 
change and which ones may need to be refined. The Ohio 
Department of Health (ODH) contracted with our research 
team to evaluate the extent to which the Ohio ED Opioid 
Prescribing Guidelines have been implemented in hospitals 
with an ED in Ohio.9 As a result, this study aimed to evaluate 
the implementation of the Ohio ED Opioid Prescribing 
Guidelines and their perceived impact on hospital policies 
and practices.
Methods
study design, setting and survey development
The study design was a cross-sectional survey of ED medical 
directors, or appropriate person identified by the hospital, 
in all Ohio hospitals with an ED throughout October 
and November 2016. A 10-question survey based on the 
Ohio ED Opioid Prescribing Guidelines was developed 
by experts on the research team who have experience in 
survey design and opioid prescribing in EDs. A literature 
review and input from ODH also ensured content validity 
of the survey. The survey instrument included primarily 
closed-ended questions using a Likert-scale to evaluate 
the implementation of the guidelines and local opioid 
policies. Questions were chosen to correspond with each 
recommendation in the guideline. Additional questions 
focused on the respondents’ demographic details, strate-
gies used to implement the guidelines and the perceived 
benefits of the guidelines. Once developed, the survey 
was pretested for key elements of accessibility, usability 
and understandability by five ED medical directors and 
physicians. The final survey was then made available as a 
paper version and a web-based version using (Research 
Electronic Data Capture (REDCap)).14
selection of participants
The survey was designed to be completed by one person 
at each hospital ED in Ohio. The survey targeted ED 
medical directors or those identified by ED personnel 
as the most appropriate person to complete the survey. 
Hospitals with an ED in Ohio were identified through the 
ODH Office of Health Assurance and Licensing. As of 
September 2016, 271 hospitals were registered in Ohio; 
164 of these hospitals had an ED; however, 1 hospital had 
closed just prior to the study commencement. Hospitals’ 
mailing addresses, phone numbers and an email address 
for their respective chief executive officer (CEO) were 
obtained from hospital registration reports.
Survey distribution followed Dillman’s Tailored Design 
Method, a mixed-mode method including postal mail and 
email, augmented by telephone interviews to maximise 
the response rate.15 Dillman’s Tailored Design Method is 
Table 1 Characteristics of respondents and their hospitals 
(n=150)
Respondents’ position n (%)
Medical director 119 (79.3)
Emergency physician 19 (12.7)
Nursing director 9 (6.0)
Pharmacist 3 (2.0)
Rural
  Urban 86 (57.3)
  Rural 64 (42.7)
Region of Ohio
  Central 21 (14.0)
  Northeast 48 (32.0)
  Northwest 34 (22.7)
  Southeast 15 (10.0)
  Southwest 32 (21.3)
Hospital funding type
  Non-government not for profit 130 (86.7)
  Government non-federal 16 (10.7)
  Investor owned for profit 4 (2.7)
Hospital classification
  Short-term acute hospital 115 (76.7)
  Critical access hospital 32 (21.3)
  Children’s hospital 3 (2.0)
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based on social exchange theory, which focuses on estab-
lishing trust, increasing benefits and decreasing costs, to 
improve response rates.15 One strategy recommend by 
Dillman is to provide participants with a token of appre-
ciation in advance. This token can be as small as US$2 as 
it increases the benefit  and establishes trust.15 A US$10 
incentive was chosen as it was the smallest amount that 
could be preloaded on a prepaid credit card.
All hospitals in Ohio with an ED were initially tele-
phoned (day 0) to inform potential participants about 
the survey and to offer to complete the survey over the 
phone. If potential participants were unavailable or 
unable to complete the survey over the phone, a letter 
was mailed with a web-link to the survey and a US$10 
incentive (day 1). A letter containing a US$10 incentive 
was also mailed to the hospital’s CEO asking the CEO to 
pass the survey web-link to the potential participant (day 
1). Three days later (day 4), the letters were followed up 
with an email to both the potential participant and the 
hospital’s CEO. If no response was received, a reminder 
email was sent on day 10, a hard copy of the survey was 
mailed on day 18 and a final reminder email was sent on 
day 22. To further increase the response rate, a reminder 
was sent to rural hospitals through the ODH State Office 
of Rural Health and to ED physicians through the Ohio 
Chapter of the ACEP. These emails were sent on day 4 
with a reminder sent a week later. The most senior ED 
physicians’ responses were used for hospitals where the 
ED medical director could not be contacted or identified.
Patient and public involvement
This study was designed and conducted by the research 
team with assistance from the Ohio ODH. Patients and 
the public were not involved in this study.
Analysis
All survey data were managed using REDCap.14 Hospitals 
were classified as being urban or rural based on the Federal 
Office of Rural Health Policy definition. Descriptive statis-
tics, reported as percentages, were used to summarise the 
demographics and survey responses. All analyses were 
performed using Stata SE V.13.1 (StataCorp).
results
Characteristics of study subjects
ED personnel at 163 hospitals were contacted to partici-
pate in this study and 150 responses were received; yielding 
92% response rate. Among those that responded, 57% 
(86/150) were from urban hospitals and 43% (64/150) 
were from rural hospitals. Table 1 shows the characteris-
tics of respondents and their hospitals. The ED medical 
director completed the survey for 79% (119/150) of the 
EDs. For the remaining EDs, either an emergency physi-
cian (13%, 19/150), an ED nursing director (6%, 9/150) 
or a pharmacist (2%, 3/150) completed the survey.
Main results
Implementation of Ohio opioid prescribing policy
Overall, 75% (112/150) of respondents stated that their 
ED either had an opioid prescribing policy, was in the 
process of adopting one or was implementing guide-
lines without a specific policy. Of these 112 EDs, 72% 
(81/112) based their policy and practices on the Ohio 
ED Opioid Prescribing Guidelines. Other prescribing 
guidelines on which respondents based their policies 
and practices were the ACEP guidelines (34%, 38/112), 
the Centers for Disease Control and Prevention (CDC) 
guidelines (29%, 32/112) and the American Academy 
Figure 1 Perceived impact of the Ohio ED Opioid Prescribing Guidelines from respondents  who  follow an opioid prescribing 
policy  (n = 106). 
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of Emergency Medicine (AAEM) guidelines (13%, 
15/112).
Among the EDs that reported developing or having 
an opioid prescribing policy, the majority strongly 
agreed/agreed that the guidelines have increased the 
use of Ohio’s prescription drug monitoring programme 
(86%) and the Ohio ED Opioid Prescribing Guidelines 
have reduced inappropriate opioid prescribing (71%). 
The other potential benefits of the Ohio ED Opioid 
Prescribing Guidelines are displayed in figure 1.
The most common strategies used to implement opioid 
prescribing policies and guidelines were developing 
educational materials, adapting the educational mate-
rials locally to their patient population and using local 
opinion leaders to encourage opioid prescribing policy 
and guideline implementation (figure 2).
Figure 2 Strategies used to implement opioid prescribing policies and guidelines (n = 106). 
Table 2 Respondents’ perception of frequency of opioid treatment in the last month in their emergency department (n=134)*
Provided to patients with acute pain 
Never 1%–4% 5%–24% 25%–49% ≥50%
n (%)
Intravenous meperidine 114 (85) 13 (10) 5 (4) 0 (0) 0 (0)
Opioid prescription that: 
  Is long acting or controlled release 110 (82) 18 (13) 2 (1) 0 (0) 0 (0)
  Replaces those lost, destroyed or stolen 91 (68) 31 (23) 4 (3) 0 (0) 0 (0)
  Is for more than a 3-day supply 30 (22) 49 (37) 30 (22) 15 (11) 3 (2)
Provided to patients with chronic pain 
Intramuscular or intravenous  opioids 6 (4) 34 (25) 52 (39) 24 (18) 9 (7)
Intravenous meperidine 118 (88) 11 (8) 0 (0) 0 (0) 0 (0)
Replacement doses of opioid substitution therapy 121 (90) 5 (4) 1 (1) 0 (0) 0 (0)
Opioid prescription that: 
  Is long acting or controlled release 113 (84) 16 (12) 1 (1) 1 (1) 0 (0)
  Replaces those lost, destroyed or stolen 97 (72) 26 (19) 3 (2) 0 (0) 0 (0)
  Is for more than a 3-day supply 52 (39) 43 (32) 23 (17) 10 (7) 0 (0)
Opioid prescription for: 
  Patients who received an opioid prescription within 
past month 27 (20) 49 (37) 36 (27) 9 (7) 2 (1)
  Patients who presented with the same problem within 
past month 20 (15) 64 (48) 30 (22) 9 (7) 0 (0)
*Although there were 134 respondents, some responded as ‘do not know’ or did not complete this specific question and are not represented 
in the table.
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Opioid prescribing practices
Table 2 shows respondents’ perceptions of opioid 
prescribing practices for pain in the last month in their 
EDs. For the management of acute pain, respondents 
rarely (<5% of patients) used intravenous meperidine, 
provided a prescription for long-acting or controlled-re-
lease opioids, or replaced opioids that were lost, destroyed 
or stolen as recommended in the guidelines. However, 
one-third of respondents (33%) reported writing an 
opioid prescription for more than 3 days for 5% or more 
of their patients with acute pain. For the management of 
chronic pain, respondents rarely (<5% of patients) used 
intravenous meperidine, provided a prescription for long-
acting or controlled-release opioids, replaced opioids that 
were lost, destroyed or stolen, or provided replacement 
doses of opioid replacement therapy as recommended in 
the guidelines. However, 64% of respondents reported 
using intramuscular or intravenous opioids in 5% or 
more of their patients with chronic pain. Also, approxi-
mately one-third of respondents provided a prescription 
for opioids in 5% or more of their patients with chronic 
pain  who: (1) had received an opioid prescription from 
another provider and (2) had previously presented with 
the same problem in the last month.
Opioid prescribing procedure
Table 3 shows respondents’ perceptions of tasks 
performed, recommended in the guidelines, for any 
opioid prescription written in the last month in their EDs. 
Large variations were reported from EDs around Ohio. 
Table 3 Respondents’ perception of tasks performed when giving an opioid prescription in the last month in their ED (n=134)*
Task performed
Never 1%–4% 5%–24% 25%–49% 50%–74% 75%–95% >95%
n (%)
Confirmed identity by 
photo identification 23 (17) 4 (3) 9 (7) 2 (1) 5 (4) 23 (17) 31 (23)
Searched the Ohio 
prescription monitoring 
programme 1 (1) 8 (6) 17 (13) 25 (19) 27 (20) 33 (25) 16 (12)
Completed urine or 
other drug screen 16 (12) 50 (37) 37 (28) 7 (5) 3 (2) 4 (3) 1 (1)
Obtained records from 
other providers 16 (12) 39 (29) 24 (18) 17 (13) 8 (6) 8 (6) 7 (5)
For patients with 
chronic pain, 
contacted their routine 
opioid prescriber 7 (5) 54 (40) 34 (25) 16 (12) 9 (7) 1 (1) 1 (1)
For patients who visit 
the ED frequently, 
conducted a case 
review or management 30 (22) 30 (22) 21 (16) 13 (10) 5 (4) 18 (13) 2 (1)
Obtained a 
consultation from the 
hospital’s palliative or 
pain service 59 (44) 50 (37) 10 (7) 2 (1) 0 (0) 0 (0) 1 (1)
Had patients sign a 
pain agreement 108 (81) 14 (10) 3 (2) 1 (1) 0 (0) 1 (1) 1 (1)
Provide patients with written information on:
  Addictive nature of 
opioids 31 (23) 16 (12) 5 (4) 10 (7) 4 (3) 13 (10) 31 (23)
  Potential dangers of 
the opioid misuse 31 (23) 21 (16) 5 (4) 10 (7) 3 (2) 13 (10) 31 (23)
  Appropriate storage 
and disposal of 
opioids 43 (32) 14 (10) 8 (6) 8 (6) 3 (2) 4 (3) 24 (18)
  The facility’s 
policy regarding 
the prescribing of 
opioids 44 (33) 14 (10) 18 (13) 13 (10) 5 (4) 6 (4) 7 (5)
*Some rows do not add up to 100% (n=134) as ‘do not know’ or incomplete responses are not included in the table.
ED, emergency department.
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For example, 23% of EDs provided written information 
on the addictive nature of opioids to more than 95% of 
their patients who received an opioid prescription, while 
another 23% of EDs never did. Some recommendations 
in the guidelines were also largely not implemented. 
Over 80% of EDs never get patients who are prescribed 
an opioid to sign a pain agreement, and 44% reported 
that they never receive a consultation from the hospital’s 
palliative or pain service.
dIsCussIon
This study found that the majority of Ohio EDs are aware 
of the need to improve appropriate opioid prescribing 
and either have a hospital-based opioid prescribing policy, 
are in the process of adopting one or are implementing 
guidelines without a specific policy. Most EDs are aware 
of the Ohio ED Opioid Prescribing Guidelines and are 
using them to be more judicious in opioid prescribing 
decisions. The results of this study demonstrate that ED 
medical directors, and their delegates, in Ohio believe 
that the Ohio ED Opioid Prescribing Guidelines have 
at least been partially implemented and have formed 
the basis for hospital-level prescribing policies. Factors 
suggesting that the Ohio ED Opioid Prescribing Guide-
lines were influential include the number of respondents 
who reported familiarity, perceived impact in terms of 
improved opioid prescribing and an increase in the use 
of the Ohio prescription drug monitoring programme. 
These findings are consistent with recent evidence that 
indicated a decline in opioid prescribing by Ohio ED 
physicians since the release of the Ohio ED Opioid 
Prescribing Guidelines.13 This successful implementation 
of the guidelines may, in part, be due to the multistake-
holder input that led to the development of the guide-
lines and broad support from professional societies and 
government officials. The fact that they are being imple-
mented so widely indicates that the guidelines offer 
reasonable advice to ED physicians.
Although respondents generally reported their ED 
practices aligned with the Ohio ED Opioid Prescribing 
Guidelines, variability in ED prescribing practices was 
also observed. The largest variability in ED prescribing 
practices was the percentage of patient with chronic pain 
treated with intramuscular or intravenous opioids. Also, 
large variability was observed in the percentage of patients 
being given a prescription for an opioid for more than 3 
days, regardless if it was for chronic or acute pain. Such 
prescribing variability may highlight that these specific 
guideline recommendations may not be practical or that 
respondents generally do not agree with them. A revi-
sion of these statements and guidance on which clinical 
scenario they apply to may ensure the guidelines support 
best practices.
Furthermore, similar variability in ED practices was 
observed, including the use of Ohio’s prescription 
drug monitoring programme and education provided 
to patients. The largest variation in ED practices was 
observed for opioid prescriptions being provided to 
patients with chronic pain even though they had previ-
ously presented with the same problem or had received 
an opioid prescription from another provider in the last 
month. This lack of standardisation in the care and infor-
mation patients receive is concerning and requires addi-
tional investigation to identify their cause.
It is also acknowledged that ED physicians make a rela-
tively small contribution to the overall number of opioids 
prescribed. In Ohio, ED physicians write approximately 
5% of all opioid prescriptions.16
Hence, guidelines aimed at primary care practitioners 
that commonly prescribe opioids should also be imple-
mented, such as those developed by the GCOAT17 18 or 
the CDC.19 However, Barnett et al20 showed that long-
term opioid use is associated with initial exposure from 
high-intensity ED prescribers. As ED prescribers do not 
regularly prescribe opioids long term, it is hypothesised 
that conversion to long-term use may be driven by clinical 
‘inertia,’ whereby outpatient clinicians renew previous 
prescriptions. Our findings suggest that ED physicians may 
initiate clinical ‘inertia’ due to the fact that approximately 
30% of respondents acknowledged that they prescribed 
opioids to at least 5% of patients who presented with the 
same problem in the last month. Despite the low number 
of opioid prescriptions written in EDs, it is important to 
acknowledge that the EDs are a source of repeat as well as 
first-time opioid exposures.
Identifying patients who are using EDs for repeat 
prescriptions is particularly challenging. There is 
currently no mechanism in Ohio for ED physicians 
to track patients who move from one ED to another. 
Although the increased use of Ohio’s prescription 
drug monitoring programme could assist with this, it 
is not mandatory for ED physicians in Ohio to review 
their records if they prescribe for fewer than 7 days.21 
Our results highlight the variability of the programmes 
utilisation, with only 12% of respondents stating they 
used it for more than 95% of their patients prescribed 
an opioid in the last month. Without mandatory use 
of prescription drug monitoring programmes in EDs, 
which may be administratively cumbersome, tracking 
patients who move between EDs is beyond the current 
healthcare systems capabilities.
These findings should be considered in light of 
multiple limitations. In particular, we note that the survey 
included self-reported data, which could be influenced 
by recall or social desirability bias. The survey reported 
ED medical directors’ perceptions of prescribing prac-
tices in their ED, which may not accurately reflect indi-
vidual-level ED prescribing patterns. These data are also 
not generalisable outside of Ohio and did not include 
EDs not affiliated with hospitals. Furthermore, infor-
mation related to the morphine milligram equivalent 
per prescription was not obtained, which may provide 
additional insight into the influence of the guide-
lines. Also, the introduction of the Ohio ED Opioid 
Prescribing Guidelines occurred in parallel with other 
7Penm J, et al. BMJ Open 2018;8:e020477. doi:10.1136/bmjopen-2017-020477
Open access
national-based and state-based interventions,5 10 so it is 
not known if the Ohio ED Opioid Prescribing Guide-
lines changed prescribers’ views on opioid prescribing 
or equipped already motivated prescribers with a tool 
to defend their decision to limit opioid prescriptions. 
The latter would be consistent with a prior report 
which indicated that ED physicians used guidelines as a 
communication tool to protect themselves from liability 
and patient complaints rather than using them to influ-
ence their decision-making process.12
In conclusion, this study showed that the Ohio ED 
Opioid Prescribing Guidelines have been widely dissem-
inated, with the majority of EDs in Ohio using them to 
develop hospital-based opioid prescribing policies. The 
majority of respondents believed that opioid prescribing 
guidelines have increased the use of the Ohio prescription 
monitoring programme and have reduced inappropriate 
opioid prescribing. Although the implementation of the 
Ohio ED Opioid Prescribing Guidelines is promising, 
further efforts to promote responsible opioid prescribing 
in other specialties are also required.
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